Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,007 | -6,060 | -27,130 | -20,710 | -13,615 |
| Depreciation Amortization | 207 | 115 | 374 | 236 | 124 |
| Accounts payable and accrued liabilities | -221 | 117 | 30 | -135 | 681 |
| Other Working Capital | -1,453 | -1,301 | -158 | 143 | -2 |
| Other Operating Activity | 1,905 | 645 | 4,127 | 3,238 | 1,416 |
| Operating Cash Flow | $-10,569 | $-6,484 | $-22,757 | $-17,228 | $-11,396 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,362 | -3,233 | 30,166 | 8,914 | 13,118 |
| PPE Investments | -832 | -664 | -729 | -322 | -75 |
| Investing Cash Flow | $6,530 | $-3,897 | $29,437 | $8,592 | $13,043 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 90 | 0 | 343 | 206 | 206 |
| Financing Cash Flow | $90 | $N/A | $343 | $206 | $206 |
| Beginning Cash Position | 19,992 | 19,992 | 12,969 | 12,969 | 12,969 |
| End Cash Position | 16,043 | 9,611 | 19,992 | 4,539 | 14,822 |
| Net Cash Flow | $-3,949 | $-10,381 | $7,023 | $-8,430 | $1,853 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,569 | -6,484 | -22,757 | -17,228 | -11,396 |
| Capital Expenditure | -832 | -664 | -729 | -322 | -75 |
| Free Cash Flow | -11,401 | -7,148 | -23,486 | -17,550 | -11,471 |